Key result
Monitor-detected AF is linked to ~2.5-fold higher mortality in post-STEMI patients with reduced LVEF.
Why the study?
Up-to-date information on the incidence and prognostic impact of arrhythmias following STEMI with reduced LVEF is lacking.
Cohort (n=224)
Yes
In patients with early reduced LVEF after STEMI, continuous monitoring via ICM revealed a lower-than-expected burden of ventricular arrhythmias, but identified atrial fibrillation as a significant predictor of increased mortality.
Answers are grounded in this paper and cite their sources.
ICM monitoring post-STEMI with reduced LVEF detects arrhythmias with potential prognostic links; leaves open whether findings refine ICD selection.
BACKGROUND: Modern therapeutic strategies have reduced mortality after a ST-segment elevation acute myocardial infarction (STEMI). However, up-to-date information on the incidence and prognostic impact of arrhythmias following this event is lacking. OBJECTIVES: This study sought to evaluate the incidence and clinical impact of ambulatory arrhythmias detected by an implantable cardiac monitor (ICM) using Bluetooth connectivity and remote monitoring after STEMI. METHODS: The TeVeO study was a multicenter, prospective study of patients who survived STEMI with reduced left ventricular ejection fraction (LVEF). Patients underwent continuous electrocardiographic monitoring using an ICM after discharge. Indication for implantable cardioverter-defibrillator (ICD) placement for primary prevention was evaluated at 6 months. RESULTS: A total of 3,565 patients were hospitalized for STEMI and subsequently discharged from our institutions. Of these, 636 had an LVEF ≤40% on day 4 or later. After application of the inclusion and exclusion criteria, 224 patients (35%) were enrolled (median LVEF: 35%). After a median follow-up time of 3.1 years, the mortality rate was 3.7 per 100 patient-years. No cases of sudden arrhythmic death were observed. At 6 months, an ICD was implanted in 25 (11%) patients (23 for primary prevention, 2 for secondary prevention). During follow-up, 119 patients (53%) experienced at least 1 ambulatory arrhythmia: 39 (17%) atrial fibrillation (AF), 35 (16%) nonsustained ventricular tachycardia, 33 (15%) sinus pauses >3 seconds, 14 (6%) second-or third-degree atrioventricular block, and 5 (2.2%) sustained monomorphic ventricular tachycardia/appropriate ICD therapy. The incidence rate of nonsustained ventricular tachycardia was 5.4 and for sustained monomorphic ventricular tachycardia/appropriate ICD therapy 0.9 per 100 patient-years. Only AF was independently associated with increased mortality (adjusted HR = 2.5; P = 0.04). CONCLUSIONS: The incidence and burden of ventricular arrhythmias were lower than expected. AF was associated with an increased mortality.
No takes yet. Share an insight, caveat, or question.
Jiménez‐Candil et al. (2026) conducted a cohort in ST-segment elevation acute myocardial infarction (STEMI) with reduced left ventricular ejection fraction (n=224). Atrial fibrillation (detected by implantable cardiac monitor) vs. No atrial fibrillation was evaluated on Mortality (adjusted HR 2.5, p=0.04). In STEMI survivors with reduced LVEF, atrial fibrillation detected by an implantable cardiac monitor was independently associated with increased mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: